nomic

Nomic Bio, formerly known as nplex biosciences, is a pioneering bioengineering company that aims to make the intricate world of the human proteome as accessible and broadly understood as the human genome. Established in 2017, Nomic is headquartered in Montreal and also has a presence in Boston, harnessing cutting-edge technology to provide innovative solutions in protein profiling.

Central to Nomic's offerings is the nELISA platform, a next-generation immunoassay technology designed for high-throughput, scalable protein measurement. This platform allows for the quantification of over 200 cytokines in a seamless fashion, dramatically increasing the scale at which proteins can be analyzed and enabling researchers to glean insights into complex biological processes. With the nELISA, Nomic has revolutionized how protein data is captured, offering true multiplexing capabilities. This commitment to advancing scientific inquiry makes them a vital partner for researchers in drug discovery and biomarker identification.